Cargando…
Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected nearly 118 million people and caused ~2.6 million deaths worldwide by early 2021, during the coronavirus disease 2019 (COVID-19) pandemic. Although the majority of infected patients show mild-to-moderate symptoms, a small frac...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245638/ https://www.ncbi.nlm.nih.gov/pubmed/34193864 http://dx.doi.org/10.1038/s41536-021-00147-x |